Janney Montgomery Scott LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
Janney Montgomery Scott LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$27,000
-6.9%
15,7400.0%0.00%
Q2 2022$29,000
-53.2%
15,740
-8.7%
0.00%
Q1 2022$62,000
-27.9%
17,2400.0%0.00%
Q4 2021$86,000
-31.2%
17,240
-1.1%
0.00%
-100.0%
Q3 2021$125,000
-17.8%
17,440
+6.1%
0.00%0.0%
Q2 2021$152,000
-6.2%
16,440
-5.7%
0.00%0.0%
Q1 2021$162,000
+8.0%
17,440
+3.2%
0.00%0.0%
Q4 2020$150,000
-22.7%
16,900
+1.0%
0.00%0.0%
Q3 2020$194,000
-57.9%
16,740
-2.1%
0.00%
-66.7%
Q2 2020$461,000
+290.7%
17,105
+26.7%
0.00%0.0%
Q1 2016$118,000
+15.7%
13,500
-11.5%
0.00%0.0%
Q4 2015$102,000
+15.9%
15,2500.0%0.00%
+50.0%
Q3 2015$88,000
-99.9%
15,250
-24.7%
0.00%
-33.3%
Q2 2015$165,240,000
+49.1%
20,250
+80.0%
0.00%
+50.0%
Q3 2014$110,813,000
-19.6%
11,250
-11.8%
0.00%
-33.3%
Q2 2014$137,828,00012,7500.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 570,049$221,7490.17%
GMT CAPITAL CORP 1,513,500$588,7520.02%
Cedar Brook Financial Partners, LLC 130,522$50,7730.01%
Arlington Capital Management, Inc. 27,735$10,7890.01%
GSA CAPITAL PARTNERS LLP 296,948$1160.01%
Keystone Financial Group 109,897$42,7510.01%
Hennion & Walsh Asset Management, Inc. 163,562$63,6260.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,149,974$447,3400.00%
Freedom Investment Management, Inc. 62,298$24,2340.00%
Renaissance Technologies 4,889,500$1,9020.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders